Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rhema Health Products is a contract development and manufacturing organization (CDMO) specializing in the health and wellness sector. The company provides comprehensive services for natural health products, dietary supplements, and over-the-counter pharmaceuticals, including custom formulation, powder blending, encapsulation, and packaging. Operating out of GMP-certified facilities in Canada, Rhema serves a diverse global customer base ranging from boutique brands to large multinational corporations. Their expertise includes specialized delivery systems such as high-speed encapsulation and complex powder filling. In 2021, the company was acquired by KDC/ONE, a global provider of manufacturing solutions, which integrated Rhema into its broader health and beauty network. This acquisition has allowed Rhema to leverage expanded resources while maintaining its focus on quality and innovation in the nutraceutical space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Rhema Group.